• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cv Sciences Inc (OP:CVSI)

0.0301 -0.0007 (-2.27%)
Streaming Delayed Price Updated: 3:26 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cv Sciences Inc

News headline image
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results
May 14, 2026
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026
May 12, 2026
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results
March 26, 2026
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026
March 24, 2026
Via ACCESS Newswire
News headline image
CV Sciences Unveils New Aura Collection THC Fizz Tablets
February 05, 2025
Via ACCESS Newswire
News headline image
CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth
March 10, 2026
Via ACCESS Newswire
News headline image
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness
February 26, 2026
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
December 22, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results
November 13, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
November 10, 2025
Via ACCESS Newswire
News headline image
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus
August 26, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
August 13, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025
August 08, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3
June 23, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
May 14, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025
May 09, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
March 27, 2025
Via ACCESS Newswire
News headline image
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods
March 26, 2025
Via ACCESS Newswire
News headline image
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
March 20, 2025
Via ACCESS Newswire
Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028
November 15, 2021
Palm Beach, FL – November 15, 2021 – FinancialNewsMedia.com News Commentary – Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects.... 
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap